We track 48 organisations in this sector across 6+ countries.
48 entries.
Accelerates cancer immunotherapy development with its HLA-Compass platform, a large quantitative database of HLA peptide presentation. AI-driven analytics predict off-target toxicity and support target discovery for safer, more precise therapies.
Aptamedica is a Warsaw-based medtech startup developing a real-time, point-of-care therapeutic drug monitoring platform for intensive and critical care. Its core product, AptaSense, is a bedside analyzer that uses single-use, aptamer-based (DNA biosensor) test strips to measure blood concentrations of antibiotics such as vancomycin, gentamicin and amikacin, plus the sepsis biomarker procalcitonin, returning results in roughly one minute from a venous sample — removing the need to send samples to a central lab and enabling immediate, precise dosing. The platform extends beyond the handheld analyzer: AptaFlow integrates into haemodialysis circuits for continuous real-time drug monitoring, while AptaSoft is an AI-assisted dosing tool aimed at neonatal care. New analytes such as troponin and digoxin are in the development pipeline and can be added via software. Founded by Maciej Łach, Mateusz Fil and Kamil Pawełkiewicz, the company is at prototype stage and has taken part in Polish innovation programmes including Warsaw Booster and the Mother and Child Startup Challenge; no external funding round has been publicly disclosed to date.
Develops a patented near-infrared fluorescent coating (NICE) for surgical instruments, letting surgeons visualise tools inside the body during minimally invasive procedures. Spun out of Strasbourg's Laboratory of Bioimaging and Pathologies.
Europe's leading partnering event for early-stage life-sciences innovation and technology transfer, in its 15th edition at Parc Chanot in Marseille. Built around one-on-one partnering meetings, it is ideal for biotech and medtech founders seeking licensing deals, academic collaborations, and early investors.
Clinical Accelerator is a Contract Research Organization (CRO) specializing in early-stage medical device clinical trials, with a focus on First-in-Human and Early Feasibility studies. The organization conducts clinical research across Eastern Europe and Central Asia, serving 100+ medical technology sponsors globally. Headquartered in Douglas, Isle of Man, it annually organizes the Georgia MedTech Innovation Summit (GMIS) in Tbilisi, convening physicians, investors, industry leaders, and medtech entrepreneurs around cardiovascular and interventional medicine innovation.
CurifyLabs is a Helsinki-based HealthTech company automating the production of personalised medicines. Its Compounding System Solution combines proprietary software, GMP-manufactured excipient bases, and 3D-printing hardware (including the PharmaPrinter Aurum) to let pharmacies compound and dispense custom-dosed medications up to nine times faster than manual methods. Founded in 2021 by Charlotta Topelius and Niklas Sandler — a professor of pharmaceutical technology at Åbo Akademi University with over a decade researching automated compounding — the company's technology is already in use across pharmacies in 21 U.S. states and multiple European countries. In July 2026, CurifyLabs closed a $14 million Series A, co-led by Sandwater and HealthCap with participation from Tesi (Finnish Industry Investment Ltd.) and existing investor Lifeline Ventures, to expand its compounding platform.
Dawn Health develops regulated software-as-a-medical-device products with pharmaceutical and life-science partners. The company builds digital therapeutics and companion applications for adherence, remote monitoring, and real-world clinical data capture in regulated settings.
AI-powered digital pathology company pairing artificial intelligence with a global network of expert pathologists. Its Diagnexia (clinical) and Patholytix (preclinical) platforms speed diagnosis and ease the pathologist shortage. Founded 2017.
Distalmotion develops Dexter, a hybrid robotic surgery platform intended to make robotic-assisted minimally invasive procedures more accessible to a broader hospital base. The system allows surgeons to move between robotic and laparoscopic workflows during operations to improve flexibility and operating-room integration.
Organizer of DMEA, Europe's leading digital health and healthcare IT trade fair held annually in Berlin. Drawing over 16,000 attendees and 700 exhibitors, DMEA showcases innovations in electronic health records, telemedicine, AI diagnostics, and hospital IT infrastructure, serving as a key meeting point for healthtech startups and health system leaders.
Europe's largest digital health trade fair at Messe Berlin, spanning healthcare IT, procurement, interoperability, and compliant medical software rollout. Includes the 'DMEA fuer Health Startups' program, the DMEA nova Award startup finals, and DMEA Sparks pitch visibility for early-stage health-tech companies.
Specialist cardiology congress in Paris focused on heart rhythm disorders, arrhythmia management, and electrophysiology innovation. Attracts 5,000+ clinicians, device manufacturers, and researchers. Registration costs about EUR 600-1000. Particularly relevant for ECG AI, cardiac monitoring, and implantable device startups seeking clinical validation and distribution partners.
A week-long showcase of Estonia's e-health, healthtech, and biotech ecosystem, opening in Tallinn and moving to Tartu, and including the DTx New Nordics Conference. Free to attend, designed for healthtech entrepreneurs, startups, clinicians, and investors.
Southern Sweden's biggest electronics-industry expo at Sparbanken Skåne Arena, targeting design and purchasing professionals across smart city, transport, and medtech. Relevant for hardware founders in the Öresund region.
A Radboudumc spin-off developing a patented AR projector that overlays anatomical data — blood vessels, muscles, nerves — directly onto a patient's skin during surgery, without screens or headsets. Used in 400+ surgeries.
Experior Venture Fund is a Warsaw-based venture capital firm that invests in early-stage technology startups, notably in fintech, medtech and digital services, typically at seed and Series A stages. One of Poland's prominent independent VCs, it is known for being co-led by women investors and backs founders across Central and Eastern Europe.
A two-day summit at the Dublin Royal Convention Centre joining clinicians, hospital managers, pharma, health-tech firms, and policy people. Relevant for digital-health and medtech founders seeking healthcare buyers and partners.
A biennial gathering at Campus Biotech, one of the largest global health conferences, bringing political, private, academic, and civil-society actors together on global health innovation and policy. For a healthtech founder in the Romandie it is the marquee venue to reach NGOs, multilateral health bodies, and impact funders.
A two-day NHS innovation festival with six distinct shows under one roof and hundreds of speakers at the Business Design Centre, London. For a healthtech founder it offers concentrated access to NHS leaders, clinicians, and health investors — useful for validation, partnerships, and early traction.
Basque Country medical robotics company developing AI-powered exoskeletons for neurological rehabilitation. Its devices combine neuromodulation techniques with wearable robotics to help patients with stroke, spinal cord injury, or multiple sclerosis regain walking ability under clinical supervision. Featured at VivaTech 2026 in Paris.
Gravity Ventures is a deep-tech startup incubator and venture builder based in Nicosia, operated by the Cyprus Research and Innovation Centre (CyRIC). Founded in 2016, it is described as the only deep-tech incubator in Cyprus, supporting startups in robotics, AI, IoT, photonics, advanced manufacturing, and MedTech. The programme covers idea validation, product design, prototyping, mentoring, commercialisation, IP protection, and funding access. Gravity Ventures has incubated 18 startups and invested over €10 million across its portfolio.
High Tech Campus Eindhoven is one of Europe's most concentrated technology innovation ecosystems, hosting over 300 companies and 12,000 researchers, developers, and entrepreneurs on a single 100-hectare campus in the south of the Netherlands. Originally developed by Philips as its corporate research campus in the 1990s, HTCE was opened to external companies in 2003 and has since evolved into a thriving open-innovation community often called 'the smartest square kilometer in Europe.' The campus specializes in hardware, semiconductors, photonics, medtech, AI, and IoT, anchored by the presence of NXP Semiconductors, Philips, and ASML nearby. Startups on the campus benefit from shared R&D facilities including cleanrooms, prototyping labs, and testing equipment that would otherwise be inaccessible at early stages. HTCE also operates the HighTechXL accelerator on-site, providing deep-tech startups with structured programs, ESA and CERN technology transfer partnerships, and investor introductions.
Hiventures is Hungary's largest state-backed venture capital firm, operating under the Hungarian Development Bank Group with approximately €258 million under management. Founded in 1999, it is the most active VC in Central and Eastern Europe by deal count, with over 420 investments made to date. The firm focuses exclusively on Hungarian startups and invests across all stages from pre-seed through growth, with a current thematic emphasis on AI, DeepTech, MedTech, and GreenTech. Its co-investment model and patient capital approach make it the primary first institutional money for Hungarian founders.
Organizer of HLTH Europe, a major health innovation conference connecting digital health startups with healthcare decision-makers in Amsterdam. Launched as the European sister event of the US-based HLTH conference, it brings together thousands of healthtech founders, hospital administrators, and investors to drive digital transformation in healthcare.
Pan-European health innovation conference at RAI Amsterdam connecting providers, payers, pharma, policymakers, and digital health startups. Strong entry point for navigating fragmented national healthcare systems through centralized buyer and partner access.
Founded in 2016 by Davide Turco, Elizabeth Tosto, Antonella Grassigli, and Alvise Bonivento, Indaco Venture Partners SGR is Italy's largest independent venture capital management company, with over €350 million in assets under management across six funds. The firm specialises in proprietary-technology companies at Series A and B, with deep expertise in electronics, robotics, medtech, advanced materials, and digital sectors. Notable portfolio companies include Newronika (adaptive deep brain stimulation), Sibylla Biotech, Almawave, and Codasip; exits include Silicon Biosystems and Directa Plus. Indaco's differentiated focus on hardware-intensive and science-driven startups sets it apart from Italy's mostly software-focused VC landscape.
Develops patent-pending faecal management briefs that contain stool in a disposable pouch immediately after excretion, cutting stool-to-skin contact and care-change time. Founded after the founder lost his father to pancreatic cancer. Targets care homes, hospitals and domiciliary care.
Angel investor and board member at COBIN Angels, Kasia is based in Switzerland and helps connect Swiss and Polish startup ecosystems. She is vice-president of the Swiss-Polish Blockchain Association and brings specialization in health economics. Her portfolio and advisory focus include Bitfold and early-stage teams using blockchain in healthcare data management and security.
Managing Partner and co-founder of Hard2beat. He previously ran the Shape VC BRIdge Alpha programme (36 portfolio companies, 2019–2023) and now invests in early-stage Polish deep-tech startups across cybersecurity, medtech, biotech and dual-use technologies.
Medical device company commercializing ReActiv8, an implantable restorative neurostimulation system that treats disabling mechanical chronic low back pain by stimulating the lumbar multifidus muscle. HQ in Dublin.
Robotic microsurgery company behind the Symani Surgical System, pairing the world's smallest wristed NanoWrist instruments with tremor reduction and motion scaling for open soft-tissue microsurgery. FDA clearance 2024.
Lucerne-based exhibition and congress organizer running industrial and trade events across central Switzerland. It hosts Swiss Medtech Expo, the country's leading biennial medtech trade fair for development, manufacturing and supply, bringing together engineers, manufacturers, suppliers and medtech startups.
Develops MSIcare, bioinformatics software that analyses microsatellite instability biomarkers from next-generation sequencing data to guide oncologists in selecting targeted immunotherapy across cancer types. Winner of France's i-Lab 2023.
Neulogy Ventures is one of the leading deeptech venture capital funds in Central and Eastern Europe, established in 2014 and operating from Bratislava with a Luxembourg fund structure. It manages €65 million in assets under management across approximately 30 portfolio companies in 10 countries, writing cheques of €200,000–€3 million primarily at Seed and Series A stages. The fund targets mission-driven Slovak and CEE technology companies addressing climate change, healthcare, and industrial automation. Institutional co-investors include the European Investment Fund, Slovak Investment Holding, and Tatra banka.
Polish-Israeli medtech startup developing VGuard, a non-invasive vagus nerve stimulation system aimed at improving cognitive outcomes in patients with Alzheimer’s disease and dementia. The company is advancing clinical validation and regulatory pathways across Europe and the US.
Medical-device company developing bimodal neuromodulation technology. Its flagship product Lenire is the first FDA-approved bimodal neuromodulation tinnitus treatment, available in 130+ clinics across the US and Europe. Founded 2010.
A two-day Nordic deep-tech and research-commercialisation matchmaking fair at Industriens Hus in Copenhagen under the 2026 theme of defence, resilience and safety. Tracks cover quantum, AI and digital, greentech and food, biotech and pharma, and medtech and diagnostics, connecting startups, researchers and industry across the Nordics.
Founded in 2015, Panakes Partners is a Milan-based healthcare VC investing EUR 1-8M at Series A and B in medical devices, diagnostics, digital health, and biotech across Europe. The firm manages over EUR 100M and focuses on companies with clear clinical evidence and regulatory pathways. Portfolio includes MMI (surgical robotics, IPO on Euronext), Novavido, and Kither Biotech. The team of medtech executives and clinicians provides hands-on support in clinical trials, CE marking, and commercialization.
HealthTech company offering a CE-certified at-home finger-prick blood collection kit and digital platform; samples ship to partner labs and users get lab-grade results for 30+ tests within 24 hours.
Develops grain-of-rice-sized microrobots designed to navigate inside the human brain to deliver therapeutic molecules, implant electrodes or collect cellular data, aiming to make neurosurgery safer and more precise for conditions including glioblastoma.
Major French healthcare and hospital innovation expo with a large innovation village for digital health ventures. High-value event for founders targeting public-hospital procurement and clinical pilot partnerships.
Semirobotics is a Warsaw-based medtech robotics startup that developed FIDI, an assistive feeding robot designed for people with upper-limb disabilities who cannot eat independently. The system combines 3D vision, AI-based motion planning, and adaptive utensils to align with the user's posture, pace, and food preferences, restoring dignity and autonomy during meals. Semirobotics targets hospitals, care homes, and individual users, addressing a significant unmet need in assistive technology. The company is part of Poland's emerging robotics and medtech scene and has received EU innovation funding.
Switzerland's leading biennial medtech trade fair for development, manufacturing and supply, organized by Messe Luzern. Around two hundred exhibitors plus a conference and innovation program draw engineers, manufacturers, suppliers and medtech startups. It is relevant to medtech founders for sourcing, partnerships and showcasing solutions in one of Switzerland's strongest industrial clusters.
Sword Health is a Portuguese digital health company focused on musculoskeletal care delivered through a mix of sensors, software, and remote clinical support. The company became prominent by showing that physical therapy does not need to depend entirely on repeated in-person visits when patient motion can be measured remotely and paired with continuous guidance from licensed professionals. Its model combines wearable motion tracking, AI-assisted feedback, and human clinicians into a structured care program that large employers and health plans can offer at scale. That makes Sword Health more than a telehealth app; it is a vertically integrated care-delivery product with hardware, data, and clinical workflow built together. In the European startup ecosystem, Sword Health is a strong example of how deep health-tech products can emerge from the region and sell into highly demanding enterprise buyers in healthcare and HR. It also broadens the directory's coverage of sensor-driven health platforms by linking medical use cases with the kinds of product, data, and device capabilities that have made other European health companies successful.
Velocity.Partners was founded in 2017 in Athens, growing out of the Found.ation startup ecosystem, and is supported by the EquiFund programme and the EU Operational Programme "Competitiveness, Entrepreneurship & Innovation". The fund is sector-agnostic but has particular depth in Maritime-tech, MedTech, FinTech, and Travel-tech — verticals where Greek founders hold a structural edge. It invests at pre-seed and seed stage with initial tickets typically up to €500K, then follows on into later rounds. The team combines operators, founders, and investors with hands-on industry experience.
Venture Catalysts is an innovative venture studio and venture builder program based in Porto, Portugal, specializing in spinning up companies from scientific research and technical projects. Founded around 2015 (with roots as a university initiative), Venture Catalysts takes a hands-on approach to pair scientists and engineers with business co-founders to create startups in fields like medtech, cleantech, and AI. The program identifies promising technologies (often from local universities like University of Porto or from labs across Portugal) and provides a structured process to form a company, develop an MVP, and obtain early funding. Each year, it selects a batch of projects and offers resources such as lab access, initial capital (seed grants or investment from partnered funds), and a network of corporate partners for pilots. A distinctive feature is how it integrates venture building with funding: Venture Catalysts can provide seed capital through grants or its partnered VC funds (often up to €200k), and also connects teams with larger investors for follow-ons. The studio’s track record includes helping create SWORD Health (digital physiotherapy startup that became a unicorn) and AddVolt (electric truck battery solution acquired by Daimler). These successes highlight the model’s efficacy – both companies started as technical projects in Portugal and through Venture Catalysts’ support, gained product-market fit and international traction. The venture studio is backed by both private and public stakeholders (it has worked with Portugal’s innovation agency and corporates like EDP in energy tech). Located in Porto’s up-and-coming innovation district, Venture Catalysts has contributed to making Porto a deep-tech startup hub beyond the usual Lisbon scene. The program puts heavy emphasis on team formation – often recruiting experienced entrepreneurs or MBAs to join scientific founders as CEOs or business leads, ensuring startups have both technical depth and commercial acumen. With a regional focus, it has kept many high-tech startups in Northern Portugal, strengthening the local ecosystem. In summary, Venture Catalysts serves as a venture co-founder for scientists – turning lab breakthroughs into viable companies by providing the missing pieces (business talent, early capital, industry links). Its portfolio’s achievements, like SWORD Health’s growth, demonstrate the powerful potential of the venture studio model in catalyzing innovation.
YES!Delft is a renowned tech incubator in the Netherlands, focused on turning university research and technical inventions into successful startups. Founded in 2005 by Delft University of Technology (TU Delft) – one of Europe’s top engineering schools – YES!Delft has grown into a deep-tech startup ecosystem supporting hardware and high-tech software ventures. The incubator offers a 3-4 month validation program for idea-stage teams, longer-term incubation for growth-stage startups, access to specialized labs and maker spaces, and connections to TU Delft’s extensive research facilities. Over the past 20 years, YES!Delft has incubated nearly 500 startups, collectively valued at over €1.2B. Notable alumni include Ampelmann (offshore access systems, now a global marine company) and E-nevia (electric mobility). The sectors span AI, robotics, medtech, aerospace, clean energy, and more – reflecting Delft’s engineering strengths. The incubator actively leverages partnerships: it works with corporates like KLM (aviation) and NS (railways) for pilot opportunities, and with government initiatives for grants. Startups at YES!Delft benefit from an entrepreneur-centric approach; the incubator was twice ranked a global top 5 university incubator by UBI Index. It offers an in-house venture fund (UNIIQ) that provides proof-of-concept funding (~€100k) to the most promising teams, bridging the gap to seed rounds. YES!Delft’s campus in Delft has co-working, an auditorium for events, and proximity to cutting-edge labs (e.g., quantum computing labs at QuTech). It has expanded with satellite branches in Rotterdam (focused on port and logistics tech) and The Hague (focused on AI and security) to tap regional industries. The name YES stands for “Young Entrepreneurs Society,” underscoring its community vibe: seasoned mentors, many of whom are TU Delft alumni entrepreneurs, guide newcomers. With continued support from TU Delft and the city, YES!Delft is a cornerstone of the Dutch innovation ecosystem – ensuring that inventions from classrooms and labs (like next-gen drones, solar cars, or medical devices) find their way to market via robust startups.
Impact investor and founder of the Humanites Institute, Zofia is a leading advocate of human-centric technology and responsible innovation. A former C-level executive in large financial organizations (including PZU and Link4), she supports startups and boards at the intersection of business performance and social impact. Her focus areas include fintech, medtech, and social impact, complemented by board service at major public companies and active mentorship.